Mark Pruzanski, CEO & President at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 5,000 shares at $300.00 ($1.5M) on 2015-05-14, disclosed to the SEC on 2015-05-18.
Scheduled sale ($1.5M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | BUY | 2018-04-09 | $500K | — | Filing → |